TAMSULOSIN HYDROCHLORIDE

Post-LOE

tamsulosin hydrochloride

ANDAORALCAPSULE
Approved
Apr 2010
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
17

Clinical Trials (5)

NCT02757768Phase 4Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Started Jun 2016
715 enrolled
Benign Prostatic HyperplasiaOveractive Bladder
NCT02509104Phase 1Completed

Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects

Started Jul 2015
56 enrolled
Prostatic Hyperplasia
NCT02184585Phase 1Completed

Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States

Started Jul 2014
84 enrolled
Prostatic Hyperplasia
NCT02169713Phase 1Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

Started May 2014
20 enrolled
Healthy SubjectsPharmacokineticsDrug-Drug Interaction (DDI)
NCT02052713Phase 1Completed

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State

Started Feb 2014
78 enrolled
Urologic Diseases